CHIEF MEDICAL EDITOR'S PAGE
By John R. Laird, Jr, MD, Chief Medical Editor
This minimally invasive procedure is a viable treatment option for many patients with peripheral vascular disease.
By David Rosenthal, MD; Eric D. Wellons, MD; Allison B. Burkett, MD; and Paul V. Kochupura, MD
Where does excisional atherectomy work best for lower extremity arterial occlusive disease?
By Michael C. Nguyen, MD, and Lawrence A. Garcia, MD
The role of these devices for percutaneous intervention in this challenging anatomy.
By Marc Bosiers, MD; Koen Deloose, MD; Jurgen Verbist, MD; and Patrick Peeters, MD
A case-based discussion of stent graft use in this challenging anatomy.
By Subhash Banerjee, MD; Emmanouil S. Brilakis, MD, PhD; and Tony S. Das, MD
Paclitaxel-coated balloons show promise as a treatment option for intravascular interventions.
By Gunnar Tepe, MD, and Ulrich Speck, Phd
A look at some of the effective applications of this nonsurgical treatment option.
By Pranab Das, MD; Santosh K. Koshy, MD; Robert S. Dieter, MD, RVT; and Aravinda Nanjundappa, MD, RVT
Co-Principal Investigator John R. Laird Jr, MD, discusses the results and impact of this landmark SFA stenting trial.
Michael D. Dake, MD, discusses the early experiences in the Zilver PTX randomized trial and the results seen in the larger global registry studying a paclitaxel-eluting stent in the SFA.
Krishna Rocha-Singh, MD, FACC, FSCAI, discusses the current status of the DURABILITY II trial, a challenging landmark study of patency and fracture resistance of stenting in the superficial femoral and popliteal arteries.
CODING & REIMBURSEMENT
The Correct Coding Initiative policy decision is good news for endovascular physicians.
By Jackie Miller, RHIA, CPC
A leading interventional radiologist discusses vascular closure, differences between CE Mark and FDA approval, and highlights of his current research.